§ 12-15-35-20.5 — Therapeutics committee established; members; limitations; terms; votes; meetings

Indiana § 12-15-35-20.5

• Jurisdiction: Indiana
• Art. 15: MEDICAID
• Ch. 35: Drug Utilization Review

Text

5. (a) The therapeutics committee is
established as a subcommittee of the board.
(b) The chairperson of the board elected under section 25 of this
chapter shall, with the approval of a majority of a quorum of the board,
appoint the members of the therapeutics committee.
(c) The therapeutics committee is composed of the following
members:
(1) Five (5) physicians licensed under IC 25-22.5, including:
(A) one (1) physician with expertise in the area of family
practice;
(B) one (1) physician with expertise in the area of pediatrics;
(C) one (1) physician with expertise in the area of geriatrics;
(D) one (1) physician with expertise in psychiatric medicine;
and
(E) one (1) physician with expertise in the area of internal
medicine and who specializes in the treatment of diabetes.
(2) Two (2) pharmacists who are licensed under IC 25-26 and
who have a doctor of pharmacy degree or an equivalent degree.
(3) One (1) member from the mental health Medicaid quality
advisory committee established by section 51 of this chapter.
(d) Not more than three (3) of the individuals appointed by the
chairperson under subsection (b) to the therapeutics committee may
also be members of the board.
(e) At least three (3) of the members described in subsection (c)(1)
and appointed under subsection (b) must have at least three (3) years
of recent experience in prescription drug formulary management,
including therapeutic category review.
(f) A member of the therapeutics committee may not:
(1) be employed by; or
(2) contract with;
the state or a pharmaceutical manufacturer or labeler. However, this
subsection does not apply to a physician or a pharmacist whose only
contract with the state is a Medicaid provider agreement under IC 12-15-11 or a provider agreement under the children's health insurance
program under IC 12-17.6.
(g) The term of a member of the therapeutics committee is three (3)
years. A member may be reappointed to the committee upon the
completion of the member's term.
(h) The expenses of the therapeutics committee shall be paid by the
office.
(i) Each member of the therapeutics committee is entitled to the
minimum salary per diem provided by IC 4-10-11-2.1(b). The member
is also entitled to reimbursement for traveling expenses as provided
under IC 4-13-1-4 and other expenses actually incurred in connection
with the member's duties as provided in the state policies and
procedures established by the Indiana department of administration and
approved by the budget agency.
(j) The affirmative votes of a majority of a quorum of the
therapeutics committee are required for the committee to take action on
any measure. A quorum of the therapeutics committee consists of four
(4) members.
(k) The therapeutics committee shall meet:
(1) upon the call of the chairperson of the therapeutics committee;
and
(2) at least quarterly.
(l) The chairperson and the vice chairperson of the therapeutics
committee:
(1) each serve for a term of one (1) year; and
(2) must be elected from the therapeutics committee's
membership at the therapeutics committee's first meeting each
calendar year.
(m) A meeting held by the therapeutics committee must be open to
the public in accordance with IC 5-14-1.5. However, the therapeutics
committee may meet in executive session only for the purpose of
reviewing confidential or proprietary information.

Legislative History

As added by P.L.107-2002, SEC.15. Amended by P.L.213-2025, SEC.113.